Daniel P. van Plew, EVP & General Mgr Industrial O at REGENERON PHARMACEUTICALS, INC. (REGN), sold 120,362 shares at $563.58 ($67.5M) on 2020-05-07, disclosed to the SEC on 2020-05-08.
Seasonal sale ($67.5M) by EVP & General Mgr Industrial O — this insider has traded REGN in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $555.77 | 28,217 | $15.7M | 23.2% |
| 2 | $555.77 | 17,779 | $9.9M | 14.6% |
| 3 | $556.92 | 100 | $56K | 0.1% |
| 4 | $556.92 | 100 | $56K | 0.1% |
| 5 | $557.59 | 600 | $335K | 0.5% |
| 6 | $558.43 | 2,118 |
| $1.2M |
| 1.8% |
| 7 | $558.43 | 2,118 | $1.2M | 1.8% |
| 8 | $559.20 | 500 | $280K | 0.4% |
| 9 | $560.53 | 3,231 | $1.8M | 2.7% |
| 10 | $560.53 | 3,231 | $1.8M | 2.7% |
| 11 | $561.55 | 4,988 | $2.8M | 4.1% |
| 12 | $561.55 | 4,988 | $2.8M | 4.1% |
| 13 | $562.45 | 2,077 | $1.2M | 1.7% |
| 14 | $562.45 | 2,077 | $1.2M | 1.7% |
| 15 | $563.58 | 2,195 | $1.2M | 1.8% |
| 16 | $563.58 | 2,195 | $1.2M | 1.8% |
| 17 | $564.54 | 3,000 | $1.7M | 2.5% |
| 18 | $565.49 | 5,984 | $3.4M | 5.0% |
| 19 | $565.49 | 5,984 | $3.4M | 5.0% |
| 20 | $566.47 | 7,297 | $4.1M | 6.1% |
| 21 | $566.47 | 7,297 | $4.1M | 6.1% |
| 22 | $567.35 | 3,753 | $2.1M | 3.2% |
| 23 | $567.35 | 3,753 | $2.1M | 3.2% |
| 24 | $568.57 | 3,040 | $1.7M | 2.6% |
| 25 | $568.57 | 3,040 | $1.7M | 2.6% |
| 26 | $569.42 | 700 | $399K | 0.6% |
| Total | $561.07 avg | 120,362 | $67.5M | 100% |
| Filing → |
| REGN | SELL | 2022-11-25 | $17.7M | — | Filing → |
| REGN | SELL | 2022-11-08 | $10.9M | — | Filing → |
| REGN | SELL | 2022-09-13 | $6.7M | — | Filing → |